Nicox Sa

Nicox Provides Full Year 2025 Financial Results and Corporate Update

Reminder: Last Exercise Day for Nicox June 2024 Warrants is June 19, 2026

Nicox Highlights Positive NCX 470 Phase 3 Data Confirming Therapeutic Profile at the 2026 American Glaucoma Society Annual Meeting

Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470

Nicox to Present Data from NCX 470 Phase 3 Studies at American Glaucoma Society (AGS) Annual Meeting 2026